FANSS study data presented at ESMO Asia 2025 demonstrate the feasibility of screening Asian women who do not smokePALO ALTO, Calif., Dec. 5, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of ...
Baseline LDH as a prognostic biomarker of early treatment failure in lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Model and clinical segmentation examples. (A) 71-year-old female with non-small cell lung cancer (NSCLC) from the internal test set. (B) 87-year-old male with NSCLC from the external test set. Both ...
BioMark Diagnostics ( ($TSE:BUX) ) has provided an announcement. BioMark Diagnostics Inc. and its research partners have been honored with the ...
Early findings from the FANSS study, presented at ESMO Asia 2025, point to a potential shift in how clinicians identify lung ...
As with many types of cancer, early detection of lung cancer is critical for improving health outcomes, and advances in robotic technology have become essential tools in early screening and ...
UnityPoint Health – Trinity is going small in order to make a big impact on lung cancer. Its new acquisition is called the Ion Endoluminal System, a robotic-assisted machine for minimally invasive ...
A New York City woman is using her lung cancer survival story to push for early detection, especially among nonsmokers and those in underserved communities. Colette Smith of the Bronx wrote a message ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results